|
CDKN1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.4600999999922E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.37270000044998E-07 |
| Normal-vs-Stage2 |
1.139580E-02 |
| Normal-vs-Stage3 |
5.857800E-02 |
| Normal-vs-Stage4 |
4.515600E-01 |
| Stage1-vs-Stage2 |
2.229400E-01 |
| Stage1-vs-Stage3 |
2.373000E-01 |
| Stage1-vs-Stage4 |
5.823000E-01 |
| Stage2-vs-Stage3 |
9.036800E-01 |
| Stage2-vs-Stage4 |
9.109000E-01 |
| Stage3-vs-Stage4 |
9.511000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53030000005216E-06 |
| Normal-vs-AfricanAmerican |
2.075500E-02 |
| Normal-vs-Asian |
9.739900E-02 |
| Caucasian-vs-AfricanAmerican |
2.230000E-01 |
| Caucasian-vs-Asian |
6.880600E-01 |
| AfricanAmerican-vs-Asian |
4.369200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81960000000814E-06 |
| Normal-vs-Female |
1.135780E-02 |
| Male-vs-Female |
2.381200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.20859999999967E-05 |
| Normal-vs-Extreme_Weight |
1.45259999995151E-06 |
| Normal-vs-Obese |
5.784400E-02 |
| Normal-vs-Extreme_Obese |
3.16079999995722E-06 |
| Normal_Weight-vs-Extreme_Weight |
6.736200E-01 |
| Normal_Weight-vs-Obese |
6.447900E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.964000E-01 |
| Extreme_Weight-vs-Obese |
7.090400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.466200E-01 |
| Obese-vs-Extreme_Obese |
7.840400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.494600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.723700E-03 |
| Normal-vs-Age(61-80Yrs) |
8.32319999588549E-08 |
| Normal-vs-Age(81-100Yrs) |
2.8161999998666E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.713900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.656420E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.898900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.395800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.858200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.481560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.08229999999476E-05 |
| Normal-VS-Type2 PRCC |
3.73980002521535E-09 |
| Normal-VS-KIRP CIMP |
4.717400E-01 |
| Normal-VS-Unclassified PRCC |
4.737600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.575800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.394400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.329370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.948100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.540700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.740200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29209999999436E-06 |
| Normal-vs-N1 |
7.254000E-01 |
| Normal-vs-N2 |
8.084800E-01 |
| N0-vs-N1 |
4.813600E-02 |
| N0-vs-N2 |
4.331700E-02 |
| N1-vs-N2 |
7.009800E-01 |
|
|
